Entrada Therapeutics Inc (TRDA) earnings · rev $25.4M
These earnings events as JSON? API free 100/dayEntrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
This TRDA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TRDA revenue for 2025-12-31 was $25.4M. Net income was -$143.8M. Revenue was down 87.9% from 2024-12-31 to 2025-12-31. TRDA currently screens at market cap $274.4M.
When the next TRDA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 87.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TRDA research stays on the stock page; the tape stays on the quote page.
TRDA earnings FAQ
What are TRDA's latest revenue and net income?
Latest cached Entrada Therapeutics Inc (TRDA) revenue for Dec 31, 2025 was $25.4M. Net income was -$143.8M. Statements: https://lician.com/financials/trda
What is TRDA's latest diluted EPS?
Latest cached Entrada Therapeutics Inc (TRDA) diluted EPS for Dec 31, 2025 was -$3.47.
What period does the latest TRDA earnings print cover?
The latest cached Entrada Therapeutics Inc (TRDA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did TRDA revenue change from the prior cached period?
Cached Entrada Therapeutics Inc (TRDA) revenue was down 87.9% from $210.8M (Dec 31, 2024) to $25.4M (Dec 31, 2025). Statements: https://lician.com/financials/trda
Where are TRDA earnings listed?
Cached earnings facts for Entrada Therapeutics Inc (TRDA) are listed at https://lician.com/earnings/trda. Statements: https://lician.com/financials/trda
Not investment advice.